BRIEF published on 04/25/2025 at 07:05, 9 months 21 days ago BB Biotech Q1 2025: Portfolio Adjustments Amid Volatile Market Market Volatility Investment Portfolio Biotech Sector BB Biotech FDA Approvals
PRESS RELEASE published on 04/25/2025 at 07:00, 9 months 21 days ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report covering the first three months of 2025 revealing a net loss of CHF 241 mn. More information at report.bbbiotech.ch/Q125 Financial Results Investment Company BB Biotech AG Interim Report Business Activities
PRESS RELEASE published on 04/25/2025 at 07:00, 9 months 21 days ago BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
BRIEF published on 03/19/2025 at 17:50, 10 months 27 days ago Les actionnaires de BB Biotech AG approuvent le dividende et réélisent le conseil d'administration Dividende Stratégie D'investissement Réélection Du Conseil D'administration BB Biotech Assemblée Générale Annuelle 2025
BRIEF published on 03/19/2025 at 17:50, 10 months 27 days ago BB Biotech AG Shareholders Approve Dividend and Re-Elect Board Investment Strategy Dividend Board Re-election BB Biotech AGM 2025
PRESS RELEASE published on 03/19/2025 at 17:45, 10 months 27 days ago Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share Shareholders at BB Biotech AG’s AGM approve dividend of CHF 1.80 per share and all board proposals. Re-elected board members for another term Shareholders Dividend AGM BB Biotech AG Board Proposals
BRIEF published on 02/21/2025 at 07:05, 11 months 23 days ago BB Biotech AG publie son rapport annuel 2024 Bénéfice Net Proposition De Dividende BB Biotech SA Rapport Annuel 2024 Secteur De La Biotechnologie
BRIEF published on 02/21/2025 at 07:05, 11 months 23 days ago BB Biotech AG Releases 2024 Annual Report Dividend Proposal Net Profit BB Biotech AG Biotechnology Sector 2024 Annual Report
BRIEF published on 02/21/2025 at 07:05, 11 months 23 days ago BB Biotech Navigates Biotech Sector's Early Recovery in 2024 Investment Strategy 2024 Financial Performance BB Biotech Regulatory Milestones Biotech Recovery
BRIEF published on 02/21/2025 at 07:05, 11 months 23 days ago BB Biotech navigue dans la reprise précoce du secteur biotechnologique en 2024 Stratégie D'investissement Résultats Financiers 2024 Biotechnologie BB Reprise De La Biotechnologie Étapes Réglementaires Importantes
Published on 02/14/2026 at 01:00, 2 days 8 hours ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 2 days 11 hours ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 2 days 15 hours ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 2 days 19 hours ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/16/2026 at 09:13, 28 minutes ago Sartorius Stedim Biotech releases Universal Registration Document 2025
Published on 02/16/2026 at 09:13, 28 minutes ago Sartorius Stedim Biotech publie son Document d’Enregistrement Universel 2025
Published on 02/16/2026 at 09:08, 33 minutes ago Sartorius Stedim Biotech SA: Information on Document Availability
Published on 02/16/2026 at 09:08, 33 minutes ago Sartorius Stedim Biotech SA : Communiqué de mise à disposition de documents
Published on 02/16/2026 at 07:00, 2 hours 42 minutes ago Peugeot Invest sells the remainder of its stake in LISI for €116 million
Published on 02/16/2026 at 07:00, 2 hours 42 minutes ago Peugeot Invest cède le solde de sa participation dans LISI pour 116 M€
Published on 02/13/2026 at 18:05, 2 days 15 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 2 days 15 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
